bg
R

Relmada Therapeutics (RLMD)

$000.00 0.00% ($0.00)

  • اليوم
  • الأسبوع
  • الشهر
  • السنة
  • ٥ سنوات
  • حتى اليوم
barakagetbaraka.com

عن Relmada Therapeutics (RLMD)

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for central nervous system (CNS) disorders. Its product candidate includes dextromethadone (d-methadone), REL-1017, REL-1015 (LevoCa... اقرأ أكثر

  • USD4.04
  • USD4.07
  • USD3.83
  • USD5.12
  • 44.40%
  • --
  • 1.61M
  • 331M
  • 0.24
  • 534.90%

أخبار الأسهم